Skip to search.
 BSE Up 0.15% NSE Up 0.28%
Streaming
Ticker Tape: On

Biogen Idec Inc. (BIIB)

-NasdaqGS

230.48 Down 2.14(0.92%) 7:39PM - Nasdaq Real Time Price

Add to Portfolio
Prev Close:232.62
Open:230.61
Bid:232.23 x 100
Ask:232.55 x 200
1y Target Est:221.41
Beta:1.29
Next Earnings Date:22-Jul-13BIIB Earnings announcement
Day's Range:229.35 - 232.73
52wk Range:126.39 - 238.83
Volume:159,320
Avg Vol (3m):1,382,730
Market Cap:54.71B
P/E (ttm):36.91
EPS (ttm):6.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BIIB at this time.

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.92%54.71B
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 1.17%11.91B
SUNPHARMA.NSDown 3.69%1.00T
GILD.MXDown 1.48%1.04T
» More Competitors

Key Statistics

Forward P/E (1 yr):23.47
P/S (ttm):9.79
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :8.04
Quarterly EPS Est (Jun-13) :1.90
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback